Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TQB-3804 by Chia Tai Tianqing Pharmaceutical Group for Non-Small Cell Lung Cancer: Likelihood of Approval
TQB-3804 is under clinical development by Chia Tai Tianqing Pharmaceutical Group and currently in Phase I for Non-Small Cell Lung...